alexa Intensity-Modulated Radiation Therapy (IMRT) for the Para-Nasal Sinus (PNS) Malignancies | OMICS International
ISSN: 2155-9619
Journal of Nuclear Medicine & Radiation Therapy

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Intensity-Modulated Radiation Therapy (IMRT) for the Para-Nasal Sinus (PNS) Malignancies

Aruna Turaka*

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

*Corresponding Author:
Aruna Turaka
Assistant Professor
Department of Radiation Oncology
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111, USA
Tel: 215-728-3022
Fax: 215-214-1629
E-mail: [email protected]

Received date : June 06, 2013; Accepted date : June 08, 2013; Published date : June 10, 2013

Citation: Turaka A (2013) Intensity-Modulated Radiation Therapy (IMRT) for the Para-Nasal Sinus (PNS) Malignancies. J Nucl Med Radiat Ther 4:e109. doi:10.4172/2155-9619.1000e109

Copyright: © 2013 Turaka A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Visit for more related articles at Journal of Nuclear Medicine & Radiation Therapy

Tumors of the paranasal sinuses are rare among the head and neck cancers and comprises <1% of all malignancies. Given proximity to the critical structures such as skull base, central nervous system, optic apparatus and orbits, these cancers pose a therapeutic challenge, particularly because these cancers present at an advanced stages. As majority of these patients at advanced stages, these are treated using radiation therapy with or without surgical resection. In resectable patients, surgery followed by postoperative RT is (64-74 Gy) considered standard by many centers. RT alone (70-74 Gy) along with concurrent chemotherapy is recommended in patients with unresectable disease. Elective nodal irradiation (ENI) is not considered standard due to low incidence of lymph node metastases among these patients except limited data from few centers on ENI for T3-4 stage tumors.

Radiation therapy using conventional techniques has been associated with a number of potentially severe complications, leading to radiation related injury to the visual apparatus. Ocular toxicity is a significant complication among patients treated for PNS tumors and the incidence of unilateral and bilateral blindness from radiation induced retinopathy and optic neuropathy has been as high as 30% and 10% respectively [1]. Published data showed poor local control rates for paranasal sinus malignancies with radiation therapy using different RT techniques due to the difficulties of air tissue interface interactions as well as the close proximity to the optical apparatus. Intensity-modulated radiation therapy (IMRT) offers the potential to reduce dose to critical structures while maintaining desired doses to the gross tumor volume via optimized non-uniform beam intensities [2,3]. Various studies reported improved clinical outcomes of PNS tumors treated with IMRT with excellent local control and survival rates with minimal complications including our experience at Fox Chase Cancer Center (FCCC) [4]. 31 patients with PNS malignancies were treated at FCCC with IMRT to a median dose of 60 Gy in 30 fractions. Median RT values to optic apparatus: Optic chiasm Dmax 22 Gy (range: 1-48); right and left optic nerve Dmax were 39, 37 Gy (range: 2-62; 2-65). At a median follow up of 27 months (range: 4-98), the 2- and 5-year local control and overall survival rates were 89%, 82% and 75%, 66%, respectively (Table 1). The 2-year loco-regional control rates were 89% for stage I/II and 79% for stages III/IV. There were no grade 3 or 4 ocular or salivary function related toxicities in our experience. IMRT appears to be a safe, effective treatment for para-nasal sinus malignancies.

Institution No. of patients 5-year Local control rate 5–year Overall survival
Duprez F, Ghent Univ, Belgium (2) 130 59% 52%
Wiegner EA, UCSF (3) 52 64%* @ 2 years 66% @ 2 years
Cattaneo R, FCCC (4) 31 82% 66%

Table 1: Local control and survival rates.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 11933
  • [From(publication date):
    June-2013 - Jun 21, 2018]
  • Breakdown by view type
  • HTML page views : 8144
  • PDF downloads : 3789
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7